Answers are grounded in this paper and cite their sources.
Adeno-associated virus vectors are widely used for gene delivery, yet their functional efficiency is limited by multiple intracellular bottlenecks. Here, we develop a modular vector engineering strategy that combines antibody-guided cellular entry with site-specific capsid modification to enhance post-entry processes. By systematically introducing surface-exposed cysteine residues into a heparan sulfate-binding-deficient capsid, we identify a permissive position that enables efficient chemical conjugation without compromising capsid assembly while revealing strong serotype-dependent constraints on capsid engineering. Using this optimized backbone, we implement antibody-guided delivery and conjugate a membrane-inserting peptide through polyethylene glycol linkers to enhance the post-entry efficiency. Peptide conjugation significantly increases transgene expression across multiple cell types without increasing viral uptake, indicating improved intracellular processing. Dose−response analyses further reveal a threshold-dependent behavior, in which functional enhancement becomes evident only above a critical vector input, a phenomenon consistently observed across distinct antigen−antibody pairs and extended to therapeutic transgenes. Together, these findings define a flexible and generalizable capsid modification strategy that improves productive transduction independently of intrinsic capsid tropism and provides a practical framework for next-generation gene delivery vectors.
No takes yet. Share an insight, caveat, or question.
Inano et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: